Compile Data Set for Download or QSAR
Report error Found 23 Enz. Inhib. hit(s) with all data for entry = 211
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM50030474(US9562012, rosiglitazone | CHEBI:50122 | Avandamet...)
Affinity DataIC50: 125nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228151(US9562012, 21 | (2s)-2-ethoxy-3-{4-[2-(3-methoxyph...)
Affinity DataIC50: 3.70E+3nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228140(US9562012, 10 | (2s)-2-ethoxy-n-methoxy-3-{4-[(4-m...)
Affinity DataIC50: 7.90E+3nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228150(US9562012, 20 | ethyl (2s)-2-ethoxy-3-{4-[2-(3-met...)
Affinity DataIC50: 1.09E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228137(US9562012, 7 | (2s)-2-ethoxy-3-{4-[(4-methoxypyrid...)
Affinity DataIC50: 1.18E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228129(US9562012, mitoglitazone)
Affinity DataIC50: 2.66E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228134(US9562012, 4 | ethyl (2s)-2-ethoxy-3-[4-(pyridin-2...)
Affinity DataIC50: 2.77E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228147(US9562012, 17 | ethyl (2r)-2-ethoxy-3-{4-[(2s)-2-h...)
Affinity DataIC50: 2.77E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228141(US9562012, 11 | (2s)-2-ethoxy-n-hydroxy-3-{4-[(4-m...)
Affinity DataIC50: 3.05E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228131(US9562012, 1 | ethyl (2s)-2-ethoxy-3-(4-hydroxyphe...)
Affinity DataIC50: 5.89E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228143(US9562012, 13 | (2r)-2-ethoxy-3-{4-[2-(3-methoxyph...)
Affinity DataIC50: 6.14E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228138(US9562012, 8 | (2s)-2-ethoxy-n-hydroxy-3-{4-[(4-me...)
Affinity DataIC50: 9.85E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228132(US9562012, 2 | ethyl (2r)-2-ethoxy-3-(4-hydroxyphe...)
Affinity DataIC50: 1.00E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228142(US9562012, 12 | ethyl (2r)-2-ethoxy-3-{4-[2-(3-met...)
Affinity DataIC50: 1.64E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228146(US9562012, 16 | (2r)-2-ethoxy-3-{4-[(2s)-2-hydroxy...)
Affinity DataIC50: 1.91E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228136(US9562012, 6 | ethyl (2s)-2-ethoxy-3-{4-[(4-methox...)
Affinity DataIC50: 1.95E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228145(US9562012, 15 | (2r)-2-ethoxy-n-methoxy-3-{4-[2-(3...)
Affinity DataIC50: 2.00E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228139(US9562012, 9 | (2s)-2-ethoxy-n-methoxy-3-{4-[(4-me...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228144(US9562012, 14 | (2r)-2-ethoxy-n-methoxy-3-{4-[2-(3...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228135(US9562012, 5 | (2s)-2-ethoxy-n-hydroxy-3-[4-(pyrid...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228148(US9562012, 18 | (2r)-2-ethoxy-n-hydroxy-3-{4-[(2s)...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228149(US9562012, 19 | (2r)-2-ethoxy-3-{4-[(2r)-2-hydroxy...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228133(US9562012, 3 | (2s)-2-ethoxy-n-hydroxy-3-{4-[(3-io...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails
US Patent